Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $28.9600 (3.13%) ($27.0700 - $29.0300) on Sat. Nov. 17, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.64% (three month average) | RSI | 66 | Latest Price | $28.9600(3.13%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | EDIT advances 3.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting EDIT price | EDIT will decline at least -1.82% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.82% (StdDev 3.64%) | Hourly BBV | 0 () | Intraday Trend | 4.8% | | | |
|
5 Day Moving Average | $28.22(2.62%) | 10 Day Moving Average | $28.36(2.12%) | 20 Day Moving Average | $27.28(6.16%) | To recent high | -12.7% | To recent low | 18.7% | Market Cap | $N/A | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |